Who is sponsoring NCT03358550?

NCT03358550 is sponsored by University of Applied Sciences Jena.

What drugs are being tested in NCT03358550?

Interventions in NCT03358550: Accommodation Measurement.

What condition does NCT03358550 study?

NCT03358550 studies Dark Focus of Accommodation.

Is NCT03358550 still recruiting?

NCT03358550 is currently completed. Last updated 30 November 2017.

Last reviewed 2017-11-30 · How we verify

NCT03358550

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Night Myopia and Dark Focus of Accommodation

Completed NA Last updated 30 November 2017

What this trial tests

NA trial testing Accommodation Measurement in Dark Focus of Accommodation in 39 participants. Completed in 23 March 2017.

Timeline

2 February 2017

Primary endpoint
23 March 2017

23 March 2017

Quick facts

Lead sponsor	University of Applied Sciences Jena
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	39
Start date	2 February 2017
Primary completion	23 March 2017
Estimated completion	23 March 2017
Sites	1 location across Germany

Drugs / interventions tested

Accommodation Measurement

Conditions studied

Dark Focus of Accommodation — all drugs for Dark Focus of Accommodation →

Sponsor

University of Applied Sciences Jena

Who can join

Adults 22 to 39, any sex, with Dark Focus of Accommodation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Shifts in accommodation at decreasing luminance levels are considered as principle cause for night myopia. Previous studies with laser optometers quantified the dark focus of accommodation up to 3 D. In addition to the measurement of dark focus, the aim of this study was to investigate the influence of an imaginary target at finite distances on the state of accommodation at scotopic luminance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03358550 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Applied Sciences Jena
Last refreshed: 30 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03358550.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing